Earnings Feed
Start Free
Home/Filings/4/0001493152-21-001041
4//SEC Filing

Yen Yun 4

Accession 0001493152-21-001041

CIK 0001335105other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 2:34 PM ET

Size

8.9 KB

Accession

0001493152-21-001041

Insider Transaction Report

Form 4
Period: 2021-01-06
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT
Yen Yun
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2021-01-06+50,000→ 50,000 total
    Exercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
Holdings

  • Options to Purchase Common Stock

    Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying)
    8,333

  • Warrants to Purchase Common Stock

    (indirect: By Sino-American Cancer FDD)
    Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (52,632 underlying)
    52,632

  • Options to Purchase Common Stock

    Exercise: $1.68From: 2018-08-04Exp: 2023-08-04→ Common (33,333 underlying)
    33,333

Documents

1 file

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

→
Entity typeother

Related Parties

1
  • filerCIK 0001684584

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:34 PM ET
Size
8.9 KB
View on SEC.gov